Sara Sletten Christensen1, Lisbeth Frostholm1, Eva Ørnbøl1, Andreas Schröder2. 1. The Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Nørrebrogade 44, Aarhus C, Denmark. 2. The Research Clinic for Functional Disorders and Psychosomatics, Aarhus University Hospital, Nørrebrogade 44, Aarhus C, Denmark. Electronic address: andreas.schroeder@aarhus.rm.dk.
Abstract
OBJECTIVE: Although there is substantial evidence that cognitive behavioural therapy alleviates symptoms in functional somatic syndromes, the mechanisms of change are less investigated. This study examined whether changes in illness perceptions mediated the effect of cognitive behavioural therapy. METHODS: We analysed additional data from a randomised controlled trial comparing completers of cognitive behavioural group therapy (46 patients) to an enhanced usual care group (66 patients). Proposed mediators (illness perceptions) and primary (physical health) and secondary (somatic symptoms and illness worry) outcomes were assessed by means of questionnaires at referral, baseline, end of treatment, and 10 and 16 months after randomisation. Multiple mediation analysis determined whether (1) changes in specific illness perceptions during treatment mediated the effect of cognitive behavioural therapy (primary analysis), and (2) whether changes in illness perceptions during the whole trial period were associated with improved outcome (secondary analysis). RESULTS: Improvements in illness perceptions during treatment partially mediated the effect of cognitive behavioural therapy on physical health one year after treatment (sum of indirect effects 1.556, BCa 95% CI (0.006; 3.620)). Improving perceived control was particularly important. Changes in illness perceptions from baseline to 16 months after randomisation were associated with clinically meaningful improvements in physical health, somatic symptoms and illness worry during the same period. CONCLUSION: Our results suggest that changing patients' illness perceptions is an important process in cognitive behavioural therapy for functional somatic syndromes. Challenging patients' own understanding of their illness may hence be a key element of successful treatment.
RCT Entities:
OBJECTIVE: Although there is substantial evidence that cognitive behavioural therapy alleviates symptoms in functional somatic syndromes, the mechanisms of change are less investigated. This study examined whether changes in illness perceptions mediated the effect of cognitive behavioural therapy. METHODS: We analysed additional data from a randomised controlled trial comparing completers of cognitive behavioural group therapy (46 patients) to an enhanced usual care group (66 patients). Proposed mediators (illness perceptions) and primary (physical health) and secondary (somatic symptoms and illness worry) outcomes were assessed by means of questionnaires at referral, baseline, end of treatment, and 10 and 16 months after randomisation. Multiple mediation analysis determined whether (1) changes in specific illness perceptions during treatment mediated the effect of cognitive behavioural therapy (primary analysis), and (2) whether changes in illness perceptions during the whole trial period were associated with improved outcome (secondary analysis). RESULTS: Improvements in illness perceptions during treatment partially mediated the effect of cognitive behavioural therapy on physical health one year after treatment (sum of indirect effects 1.556, BCa 95% CI (0.006; 3.620)). Improving perceived control was particularly important. Changes in illness perceptions from baseline to 16 months after randomisation were associated with clinically meaningful improvements in physical health, somatic symptoms and illness worry during the same period. CONCLUSION: Our results suggest that changing patients' illness perceptions is an important process in cognitive behavioural therapy for functional somatic syndromes. Challenging patients' own understanding of their illness may hence be a key element of successful treatment.
Authors: Karen Hansen Kallesøe; Andreas Schröder; Rikard K Wicksell; Per Fink; Eva Ørnbøl; Charlotte Ulrikka Rask Journal: BMJ Open Date: 2016-09-15 Impact factor: 2.692
Authors: Jessica Broughton; Sarah Harris; Lucy Beasant; Esther Crawley; Simon M Collin Journal: BMC Health Serv Res Date: 2017-06-02 Impact factor: 2.655
Authors: Fiona J R Eccles; David Craufurd; Alistair Smith; Rhys Davies; Kristian Glenny; Max Homberger; Siofra Peeren; Dawn Rogers; Leona Rose; Zara Skitt; Rachael Theed; Jane Simpson Journal: Pilot Feasibility Stud Date: 2020-06-24
Authors: Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Alexander G Bodelier; Herbert M van Wering; Pamela C W M Hurkmans; M Luisa Mearin; Andrea E van der Meulen-de Jong; Johanna C Escher; Elisabeth M W J Utens Journal: Int J Behav Med Date: 2019-08
Authors: Luuk Stapersma; Gertrude van den Brink; Jan van der Ende; Eva M Szigethy; Michael Groeneweg; Frederieke H de Bruijne; Manon H J Hillegers; Johanna C Escher; Elisabeth M W J Utens Journal: J Clin Psychol Med Settings Date: 2020-09
Authors: Miranda van Lunteren; Margreet Scharloo; Zineb Ez-Zaitouni; Anoek de Koning; Robert Landewé; Camilla Fongen; Roberta Ramonda; Ad A Kaptein; Floris A van Gaalen; Désirée van der Heijde Journal: Arthritis Care Res (Hoboken) Date: 2018-12 Impact factor: 4.794